ADMA Biologics, Inc. (NASDAQ: ADMA) is a U.S.-based biopharmaceutical company focused on developing and commercializing specialty biologics for individuals suffering from immunodeficiency. Recently, the company reported its quarterly results for the period ending March 31, 2025, indicating signif...